Evidence map›Paper›PMID 23396948›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2013

The structural wedge domain of the receptor-like tyrosine phosphatase CD45 enforces B cell tolerance by regulating substrate specificity.

Julie Zikherman, Ramya Parameswaran, Michelle Hermiston, Arthur Weiss

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Tonic Signals: Why Do Lymphocytes Bother?Trends in immunology · 2017
    Review
  5. Article
  6. Article
  7. An extracatalytic function of CD45 in B cells is mediated by CD22.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Julie ZikhermanDivision of Rheumatology, Department of Medicine, Rosalind Russell Medical Research Center for Arthritis, University of California, San Francisco, San Francisco, CA 94143, USA.
Ramya Parameswaran
Michelle Hermiston
Arthur Weiss
University of California, San Francisco · USHoward Hughes Medical Institute · USUniversity of California San Francisco Medical Center · US

Funding

Research BaseP30DK063720 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KRUMMEL, MATTHEW F · 2003 to 2019
$21.8M
Src tyrosine kinases and autoimmunity.P01AI035297 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BLUESTONE, JEFFREY A · 1993 to 2010
$16.5M
Titrating CD45 expression in mice to study development of T cell toleranceK08AR059723 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ZIKHERMAN, JULIE · 2010 to 2014
$598k
NIAID NIH HHS P01 AI035297NIAID NIH HHS P0I AI035297NIAMS NIH HHS K08 AR059723NIDDK NIH HHS P30 DK063720
6 · The paper itself

Abstract

CD45 is a receptor-like tyrosine phosphatase that positively regulates BCR signaling by dephosphorylating the inhibitory tyrosine of the Src family kinases. We showed previously that a single point mutation, E613R, introduced into the cytoplasmic membrane-proximal "wedge" domain of CD45 is sufficient to drive a lupus-like autoimmune disease on a susceptible genetic background. To clarify the molecular mechanism of this disease, we took advantage of a unique allelic series of mice in which the expression of CD45 is varied across a broad range. Although both E613R B cells and those with supraphysiologic CD45 expression exhibited hyperresponsive BCR signaling, they did so by opposite regulation of the Src family kinase Lyn. We demonstrated that the E613R allele of CD45 does not function as a hyper- or hypomorphic allele but rather alters the substrate specificity of CD45 for Lyn. Despite similarly enhancing BCR signaling, only B cells with supraphysiologic CD45 expression became anergic, whereas only mice harboring the E613R mutation developed frank autoimmunity on a susceptible genetic background. We showed that selective impairment of a Lyn-dependent negative-regulatory circuit in E613R B cells drove autoimmunity in E613R mice. This demonstrates that relaxing negative regulation of BCR signaling, rather than enhancing positive regulation, is critical for driving autoimmunity in this system.

Indexed as

Immune ToleranceAllelesAnimalsB-Lymphocyte SubsetsGenetic VariationLeukocyte Common AntigensMiceMice, Inbred C57BLMice, KnockoutMice, Mutant StrainsMice, TransgenicProtein Structure, TertiaryReceptor-Like Protein Tyrosine Phosphatasessrc-Family KinasesSubstrate SpecificityLeukocyte Common AntigensPTPRC protein, humanReceptor-Like Protein Tyrosine Phosphatasessrc-Family Kinases

Identifiers

PMID23396948
PMCPMC3593789
OpenAlexW2136179972

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.